Search by Drug Name or NDC

    NDC 71858-0140-05 Tirosint 125 ug/mL Details

    Tirosint 125 ug/mL

    Tirosint is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by IBSA Pharma Inc.. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 71858-0140
    Product ID 71858-0140_0a4370a8-688c-7d96-e063-6294a90a18b8
    Associated GPIs 28100010102060
    GCN Sequence Number 076967
    GCN Sequence Number Description levothyroxine sodium SOLUTION 125 MCG/ML ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 42819
    HICL Sequence Number 002849
    HICL Sequence Number Description LEVOTHYROXINE SODIUM
    Brand/Generic Brand
    Proprietary Name Tirosint
    Proprietary Name Suffix SOL
    Non-Proprietary Name Levothyroxine Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 125
    Active Ingredient Units ug/mL
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name IBSA Pharma Inc.
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA206977
    Listing Certified Through 2024-12-31

    Package

    NDC 71858-0140-05 (71858014005)

    NDC Package Code 71858-0140-5
    Billing NDC 71858014005
    Package 6 POUCH in 1 CARTON (71858-0140-5) / 5 AMPULE in 1 POUCH (71858-0140-4) / 1 mL in 1 AMPULE (71858-0140-6)
    Marketing Start Date 2019-03-01
    NDC Exclude Flag N
    Pricing Information N/A